4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)Neovascular Age-related Macular DegenerationRecruitingPhase 42026-10-02NCT04853251
Extension Study for the Port Delivery System With Ranibizumab (Portal)Neovascular Age-Related Macular DegenerationRecruitingPhase 32026-09-28NCT03683251
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degenerationRecruitingPhase 2 / Phase 32026-08-06NCT07496567
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenerationNeovascular Age-Related Macular DegenerationActive, not recruitingPhase 32025-04-18NCT06223958